Eirik Næss-Ulseth
Not claimed · public-source information only
0 følgereFølg
Claim this profile16 active roles in 15 companies
Board
Verified by the Brønnøysund Register Centre · cannot be changed by the person
| Company | Role | Employees | Revenue |
|---|---|---|---|
| INVENTRON AS OSLO · 884614902 · | Chair of the board | — | 0 kr 2025 |
| TOBORA AS OSLO · 933223116 · | Board member | — | 10 500 kr 2025 |
| SHARPXVIEW AS OSLO · 913402545 · | Chair of the board | — | 1 081 200 kr 2025 |
| CELLMOVER AS OSLO · 914987571 · | Board member | 6 | 2 016 775 kr 2025 |
| EQUANOSTIC AS OSLO · 918565639 · | Chair of the board | 24 | 6 570 665 kr 2025 |
| VITAE EVIDENCE AS OSLO · 929480821 · | Board member | — | 533 106 kr 2025 |
| HECOTRON INDUSTRIELL ELEKTRONIKK AS OSLO · 933574725 · | Board member | — | 15 819 739 kr 2025 |
| ARCTIC PHARMA AS OSLO · 998070120 · | Chair of the board | — | 1 018 191 kr 2025 |
| HECOTRON AS OSLO · 967301515 · | Deputy board member | — | 0 kr 2025 |
| SKILLING SYSTEMER AS OSLO · 976537165 · | Chair of the board | — | 0 kr 2025 |
| BIOMOLEX AS OSLO · 983453430 · | Chair of the board | — | 22 800 kr 2025 |
| COREMINE VITAE AS OSLO · 983558526 · | Chair of the board | — | 744 512 kr 2025 |
| PUBGENE AS OSLO · 983641350 · | Chair of the board | — | 2 237 757 kr 2025 |
| COREMINE BIL OSLO · 993075051 · | Board member | — | — |
| SPERMATECH AS OSLO · 984698542 · | Board member | — | 443 352 kr 2025 |
Management
Verified by the Brønnøysund Register Centre · cannot be changed by the person
| Company | Role | Employees | Revenue |
|---|---|---|---|
| SHARPXVIEW AS OSLO · 913402545 · | Chief executive officer | — | 1 081 200 kr 2025 |
Experiences
Reviews
Loading reviews …
Write a review
You must sign in with a verified email to write a review.
The information comes from the Brønnøysund role register and the Tax Administration shareholder register. We only show name, role and company as published by the registers – never date of birth, national ID number or private address. People with the same name may be shown together.
